← Open Payments lookup

EMILY HART: Open Payments

NPI 1578153094 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$362 in 19 payments from 9 companies in 2025. Trend: 2023 $213 · 2024 $250 · 2025 $362

Food & beverage: $362
CompanyPaymentsAmount
Biogen, Inc.4$88
Astellas Pharma US Inc5$86
ABBVIE INC.3$72
Bayer Healthcare Pharmaceuticals Inc.2$28
Daiichi Sankyo Inc.1$24
MILLICENT US INC1$19
CooperSurgical, Inc.1$16
Organon LLC1$15
Exeltis, USA Inc.1$14

Products named: ZURZUVAE, Veozah, VRAYLAR, INJECTAFER, INTRAROSA, Paragard T 380A, NEXPLANON, SLYND.

Industry payments across IN — which companies pay providers there.